How do I explain Wilson disease to a new doctor who has never seen it?
Bring a one-page summary of your diagnosis, current medication, latest labs, and treating-specialist contact. Do not expect a generalist to know Wilson disease — equip them.
Wilson disease is rare enough — affecting roughly one person in every 30,000 — that most generalists, dentists, and emergency physicians will go their entire career without seeing a single case.1 Some researchers using population-level genetic data suggest the true prevalence may be even higher, but clinical recognition often lags behind.2 The practical result is that the patient and family are often the most informed people in the room. That is not a complaint — it is a practical reality, and you can prepare for it.
Build a one-page summary
Keep this in your wallet, on your phone, and emailed to a trusted family member.
It should contain:
- Your full name, date of birth, and weight
- “I have Wilson disease (genetic copper-overload disease; ICD-10: E83.01)”
- Date of diagnosis and the diagnosing institution
- Treating hepatologist’s name, hospital, and direct contact number
- Current medications, doses, and times taken
- Drug allergies and intolerances
- Most recent labs: ALT, AST, ceruloplasmin, 24-hour urinary copper, full blood count
- A line for the new clinician: “For acute or unfamiliar issues, please call my treating hepatologist before changing medications.”
What new clinicians often miss
Do not stop my Wilson medication for routine procedures. Current guidelines advise that chelation therapy and zinc therapy should generally be continued during the perioperative period; stopping treatment carries a real risk of copper re-accumulation and acute liver decompensation.3 If your surgical or dental team believes your medication should be paused, they should call your hepatologist first — not act unilaterally.
A few other points worth putting in your summary:
- Copper-containing IUDs are contraindicated in women with Wilson disease. Both AASLD and EASL guidance agree on this point, since the device releases copper directly into the body.34 If you need contraception, discuss alternatives with your gynaecologist and hepatologist together.
- Avoid copper-containing supplements — including many formulations of “complete multivitamin,” “prenatal vitamin,” or general mineral supplements. Even moderate supplemental copper intake can be clinically significant when normal copper excretion is impaired.56
- Some psychiatric medications can interact with chelators or complicate the neurological picture; tell every prescribing clinician about your Wilson disease and your current treatment regimen.3
- Most standard contrast agents used in radiology are safe, but confirming with your specialist before any new imaging procedure is a sensible habit.
In an emergency
In an emergency room, calmly tell every clinician who walks in:
“I have Wilson disease. I take [medication] [dose] [schedule]. My hepatologist is [name] at [hospital]; their phone is [number]. Please call them if anything you are about to do changes my medication.”
Then hand them your one-page summary. Repeat for the next clinician. Repeat for the night shift.
Patient cards from associations
Several Wilson disease patient associations issue printed wallet cards that summarise the condition and key precautions for emergency staff. Two well-established organisations that offer these resources are the Wilson Disease Association (wilsondisease.org) and EuroWilson (eurowilson.org). If a card is available for your country, get one and keep it with your ID.
You are not being difficult
Insisting that a new clinician contact your specialist is not “being a difficult patient.” Rare-disease care depends on continuity and specialist communication — one casual prescribing decision, or stopping a medication for what seems like a routine reason, can cause real and rapid harm. Advocating for yourself is the responsible thing to do.
This post is for patient education and general information only. It is not a substitute for advice from your own medical team, who know your individual history and current treatment.
References
-
Czlonkowska, Anna, Tomasz Litwin, Piotr Dziezyc, Maciej Karlinski, Beata Chabik, and Anna Czerska. “Wilson Disease.” Nature Reviews Disease Primers 4, no. 1 (2018). https://doi.org/10.1038/s41572-018-0024-5. ↩
-
Gao, Jiali, Simon Brackley, and Jake P. Mann. “The Global Prevalence of Wilson Disease from Next-Generation Sequencing Data.” Genetics in Medicine 21, no. 5 (2019): 1155-1163. https://doi.org/10.1038/s41436-018-0309-9. ↩
-
Schilsky, Michael L., Eve A. Roberts, Jeff M. Bronstein, Anil Dhawan, James P. Hamilton, Anne Marie Rivard, Mary Kay Washington, Karl Heinz Weiss, and Paula C. Zimbrean. “A Multidisciplinary Approach to the Diagnosis and Management of Wilson Disease: 2022 Practice Guidance on Wilson Disease from the American Association for the Study of Liver Diseases.” Hepatology 82, no. 3 (2022): E41-E90. https://doi.org/10.1002/hep.32801. ↩↩↩
-
European Association for the Study of the Liver. “EASL Clinical Practice Guidelines: Wilson’s Disease.” Journal of Hepatology 56, no. 3 (2012): 671-685. https://doi.org/10.1016/j.jhep.2011.11.007. ↩
-
Pfeiffenberger, Jan, Sandra Beinhardt, Daniel N. Gotthardt, Nicola Haag, Clarissa Freissmuth, Ulrike Reuner, Annika Gauss, Wolfgang Stremmel, Michael L. Schilsky, Peter Ferenci, and Karl Heinz Weiss. “Pregnancy in Wilson’s Disease: Management and Outcome.” Hepatology 67, no. 4 (2018): 1261-1269. https://doi.org/10.1002/hep.29490. ↩
-
Teufel-Schäfer, Ulrike, Christine Forster, and Nikolaus Schaefer. “Low Copper Diet – A Therapeutic Option for Wilson Disease?” Children 9, no. 8 (2022): 1132. https://doi.org/10.3390/children9081132. ↩
This is patient education, not medical advice. Always consult your own clinical team about decisions for your care.